RESEARCH | QUALITY | RELIABILITY
| Sl | Particulars | View |
|---|---|---|
| a | Details of Business: | Click to view |
| (aa) Memorandum of Association and Articles of Association | Click to view | |
| (ab) Brief profile of Board of Directors including Directorships and full-time positions in body corporates | Click to view | |
| b | Terms and Conditions of Appointment of Independent Directors | Click to view |
| c | Composition of various committees of Board of Directors | Click to view |
| d | Code of Conduct of Board of Directors and Senior Management Personnel | Click to view |
| e | Details of establishment of vigil mechanism/ Whistle Blower policy | Click to view |
| f | Criteria of making payments to Non-Executive Directors | Click to view |
| g | Policy on dealing with Related Party Transactions | Click to view |
| h | Policy for determining ‘Material’ Subsidiaries | NA |
| i | Details of familiarization programmes imparted to Independent Directors | Click to view |
| j | Email address for grievance redressal and other relevant details | Click to view |
| k | Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances | Click to view |
| l | Financial Information including | |
| (i) Notice of Meeting of the Board of Directors | Click to view | |
| (ii) Financial Results | Click to view | |
| (iii) Annual Report | Click to view | |
| m | Shareholding Pattern | Click to view |
| n | Details of Agreements entered into with the media companies and/or their associates, etc | NA |
| o | Meet | |
| (i) Schedule of analysts or institutional investors meet | Click to view | |
| (ii) Presentations prepared by the listed entity for analysts or institutional investors meet, post earnings or quarterly calls prior to beginning of such events | Click to view | |
| oa | Audio recordings, video recordings, if any, and transcripts of post earnings or quarterly calls, by whatever name called, conducted physically or through digital means, in the following manner | Click to view |
| (i) The audio recordings shall be promptly made available on the website and in any case, before the next trading day or within twenty-four hours from the conclusion of such calls, whichever is earlier; | Click to view | |
| (ii) The video recordings, if any, shall be made available on the website within forty-eight hours from the conclusion of such calls | Click to view | |
| (iii) The transcripts of such calls shall be made available on the website along with simultaneous submission to recognized stock exchanges within five working days of the conclusion of such calls | Click to view | |
| p | New name and the Old name of the listed entity for a continuous period of one year, from the date of the last name change | NA |
| q | Regulation 47(1) – Newspaper Publications | Click to view |
| r | All Credit ratings obtained by the entity for all its outstanding instruments, updated immediately as and when there is any revision in any of the ratings. | Click to view |
| s | Separate Audited Financial Statements of each subsidiary of the listed entity in respect of a relevant financial year, uploaded at least 21 days prior to the date of the annual general meeting which has been called to inter alia consider accounts of that financial year | NA |
| t | Secretarial compliance report as per Regulation 24A (2) | Click to view |
| u | Disclosure of the policy for determination of materiality of events or information required under regulation 30(4)(ii) | Click to view |
| v | Contact details of Key Managerial Personnels authorised to determine Materiality of an Event | Click to view |
| w | Disclosures under Regulation 30(8) | Click to view |
| x | Statements of Deviation(s) or variation(s) as specified in regulation 32 | Click to view |
| y | Dividend Distribution Policy as specified under regulation 43A (1) | Click to view |
| z | Annual return as provided under section 92 of the Companies Act, 2013 and the rules made thereunder. | Click to view |
| za | Employee Benefit Scheme | NA |
© 2025 Anuh Pharma Ltd. – All Rights Reserved. Please Read The Disclaimer.
